These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1579 related articles for article (PubMed ID: 33712603)

  • 21. COVID-19 incidence, hospitalizations and mortality trends in Croatia and school closures.
    Simetin IP; Svajda M; Ivanko P; Dimnjakovic J; Belavic A; Istvanovic A; Poljicanin T
    Public Health; 2021 Sep; 198():164-170. PubMed ID: 34461449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020.
    Brandal LT; Ofitserova TS; Meijerink H; Rykkvin R; Lund HM; Hungnes O; Greve-Isdahl M; Bragstad K; Nygård K; Winje BA
    Euro Surveill; 2021 Jan; 26(1):. PubMed ID: 33413743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.
    Ng OT; Marimuthu K; Koh V; Pang J; Linn KZ; Sun J; De Wang L; Chia WN; Tiu C; Chan M; Ling LM; Vasoo S; Abdad MY; Chia PY; Lee TH; Lin RJ; Sadarangani SP; Chen MI; Said Z; Kurupatham L; Pung R; Wang LF; Cook AR; Leo YS; Lee VJ
    Lancet Infect Dis; 2021 Mar; 21(3):333-343. PubMed ID: 33152271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reopening schools in the context of increasing COVID-19 community transmission: The French experience.
    Gras-Le Guen C; Cohen R; Rozenberg J; Launay E; Levy-Bruhl D; Delacourt C
    Arch Pediatr; 2021 Apr; 28(3):178-185. PubMed ID: 33618971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium.
    Meuris C; Kremer C; Geerinck A; Locquet M; Bruyère O; Defêche J; Meex C; Hayette MP; Duchene L; Dellot P; Azarzar S; Maréchal N; Sauvage AS; Frippiat F; Giot JB; Léonard P; Fombellida K; Moutschen M; Durkin K; Artesi M; Bours V; Faes C; Hens N; Darcis G
    JAMA Netw Open; 2021 Oct; 4(10):e2128757. PubMed ID: 34636913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of relaxing interventions on human contact patterns and SARS-CoV-2 transmission in China.
    Zhang J; Litvinova M; Liang Y; Zheng W; Shi H; Vespignani A; Viboud C; Ajelli M; Yu H
    Sci Adv; 2021 May; 7(19):. PubMed ID: 33962957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based prospective cohort study.
    Ulyte A; Radtke T; Abela IA; Haile SR; Braun J; Jung R; Berger C; Trkola A; Fehr J; Puhan MA; Kriemler S
    Int J Public Health; 2020 Dec; 65(9):1549-1557. PubMed ID: 33063141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlling the pandemic during the SARS-CoV-2 vaccination rollout.
    Viana J; van Dorp CH; Nunes A; Gomes MC; van Boven M; Kretzschmar ME; Veldhoen M; Rozhnova G
    Nat Commun; 2021 Jun; 12(1):3674. PubMed ID: 34135335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.
    Seon JY; Jeon WH; Bae SC; Eun BL; Choung JT; Oh IH
    J Korean Med Sci; 2021 May; 36(20):e148. PubMed ID: 34032033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of anti-SARS-CoV-2 antibodies among children and their parents in Greece.
    Dimopoulou D; Kyritsi M; Dadouli K; Vergadi E; Tsiligianni E; Papadimitriou E; Mavridi A; Giannakopoulos S; Tsiourvopoulou G; Palyvou M; Angeli E; Brikos N; Eleftheriou I; Spoulou V; Michos A; Gkentzi D; Siomou E; Papaevangelou V; Grivea I; Syrogiannopoulos G; Galanakis E; Hadjichristodoulou C; Tsolia M
    Eur J Pediatr; 2023 Jan; 182(1):439-449. PubMed ID: 36383284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
    Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
    Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling the effect of lockdown timing as a COVID-19 control measure in countries with differing social contacts.
    Oraby T; Tyshenko MG; Maldonado JC; Vatcheva K; Elsaadany S; Alali WQ; Longenecker JC; Al-Zoughool M
    Sci Rep; 2021 Feb; 11(1):3354. PubMed ID: 33558571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
    Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
    Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reasons for SARS-CoV-2 infection in children and their role in the transmission of infection according to age: a case-control study.
    Calvani M; Cantiello G; Cavani M; Lacorte E; Mariani B; Panetta V; Parisi P; Parisi G; Roccabella F; Silvestri P; Vanacore N
    Ital J Pediatr; 2021 Sep; 47(1):193. PubMed ID: 34579754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmission of SARS-CoV-2 in educational settings in 2020: a review.
    Vardavas C; Nikitara K; Mathioudakis AG; Hilton Boon M; Phalkey R; Leonardi-Bee J; Pharris A; Deogan C; Suk JE
    BMJ Open; 2022 Apr; 12(4):e058308. PubMed ID: 35383084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weighing policymaking: A narrative review of school closures as COVID-19 pandemic-mitigation strategies.
    Nenna R; Zeric H; Petrarca L; Mancino E; Midulla F
    Pediatr Pulmonol; 2022 Sep; 57(9):1982-1989. PubMed ID: 34894111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A structured model for COVID-19 spread: modelling age and healthcare inequities.
    James A; Plank MJ; Binny RN; Lustig A; Hannah K; Hendy SC; Steyn N
    Math Med Biol; 2021 Aug; 38(3):299-313. PubMed ID: 34002201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 transmission across age groups in France and implications for control.
    Tran Kiem C; Bosetti P; Paireau J; Crépey P; Salje H; Lefrancq N; Fontanet A; Benamouzig D; Boëlle PY; Desenclos JC; Opatowski L; Cauchemez S
    Nat Commun; 2021 Nov; 12(1):6895. PubMed ID: 34824245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. When schools were open for in-person teaching during the COVID-19 pandemic - the nordic experience on control measures and transmission in schools during the delta wave.
    Rotevatn TA; Nygård K; Espenhain L; Legarth R; Møller KL; Sarvikivi E; Helve O; Aspelund G; Ersson A; Nordahl M; Greve-Isdahl M; Astrup E; Johansen TB
    BMC Public Health; 2023 Jan; 23(1):62. PubMed ID: 36624496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 79.